Clinical Trial Update: Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of NA-931 in adults who are overweight/obese and have type 2 d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• NA-931

Snippet

Sponsor: Biomed Industries, Inc. | Conditions: Overweight or Obesity, Type 2 Diabetes | Phase 1 | Status: COMPLETED